Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-K for the period ended Dec 31, 2012

Filed with the SEC on Apr 11, 2013 and accepted by EDGAR at Apr 11, 2013, 19:53 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2012-01-01 to 2012-12-31$921us-gaap:Revenues
Cost of revenue12 months2012-01-01 to 2012-12-31$0us-gaap:CostOfGoodsSold
Gross profit12 months2012-01-01 to 2012-12-31$921us-gaap:GrossProfit
Interest expense12 months2012-01-01 to 2012-12-31−$227us-gaap:InterestExpense
Net income12 months2012-01-01 to 2012-12-31−$27.6kus-gaap:NetIncomeLoss
Diluted EPS12 months2012-01-01 to 2012-12-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2012-01-01 to 2012-12-31−$13.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2012-12-31$1.1kus-gaap:Cash
Current assetsAt period end2012-12-31$1.1kus-gaap:AssetsCurrent
Total assetsAt period end2012-12-31$1.1kus-gaap:Assets
Current liabilitiesAt period end2012-12-31$18.4kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-12-31$18.4kus-gaap:Liabilities
Shareholders' equityAt period end2012-12-31−$17.2kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001014897-13-000108. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.